Follow
Peter Chandler
Peter Chandler
Cancer Science Institute, National University of Singapore
Verified email at nus.edu.sg - Homepage
Title
Cited by
Cited by
Year
Development and differentiation in monobodies based on the fibronectin type 3 domain
PG Chandler, AM Buckle
Cells 9 (3), 610, 2020
452020
Adjuvant therapies in venous leg ulcer management: a scoping review
V Team, PG Chandler, CD Weller
Wound Repair and Regeneration 27 (5), 562-590, 2019
432019
Strategies for increasing protein stability
PG Chandler, SS Broendum, BT Riley, MA Spence, CJ Jackson, ...
Protein Nanotechnology: Protocols, Instrumentation, and Applications, 163-181, 2020
252020
Structural studies of thyroid peroxidase show the monomer interacting with autoantibodies in thyroid autoimmune disease
DE Williams, SN Le, DE Hoke, PG Chandler, M Gora, M Godlewska, ...
Endocrinology 161 (2), bqaa016, 2020
122020
Mutational and biophysical robustness in a prestabilized monobody
PG Chandler, LL Tan, BT Porebski, JS Green, BT Riley, SS Broendum, ...
Journal of Biological Chemistry 296, 2021
62021
Polymer End Group Control through a Decarboxylative Cobalt-Mediated Radical Polymerization: New Avenues for Synthesizing Peptide, Protein, and Nanomaterial Conjugates
M Ayurini, PG Chandler, PD O’Leary, R Wang, D Rudd, KD Milewska, ...
JACS Au 2 (1), 169-177, 2021
32021
Structure and dynamics of the autoantigen GAD65 in complex with the human autoimmune polyendocrine syndrome type 2-associated autoantibody b96. 11
S Stander, CF Reboul, SN Lee, D Williams, PG Chandler, MGS Costa, ...
bioRxiv, 2024.03. 18.585568, 2024
2024
Preclinical evaluation of targeted radionuclide therapy combined with immune checkpoint inhibition
E Oosterwijk, S Kleidendorst, M Konijnenberg, R Merkx, ...
European Urology 83, S1489, 2023
2023
Preclinical evaluation of targeted radionuclide therapy combined with immune checkpoint inhibition
S Kleinendorst, M Konijnenberg, R Merkx, K Twumasi-Boateng, ...
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 49 (SUPPL 1), S58-S59, 2022
2022
Potentiation of Immune Checkpoint Inhibition with Molecular-Targeted Radiation
S Kleinendorst, P Chandler, E Oosterwijk, M Konijnenberg, ...
Journal of Nuclear Medicine 63 (supplement 2), 4039-4039, 2022
2022
Development and differentiation of hyperstable consensus monobodies based on the type 3 fibronectin domain
PG CHANDLER
Monash University, 0
The system can't perform the operation now. Try again later.
Articles 1–11